Research

Trials, publications and work in progress

Site Principal Investigator on a national real-world insulin study, investigator on two more, and a continuing publication record in Indian diabetes and internal medicine journals. ORCID is the authoritative list.

View the ORCID record Research and advisory enquiries

The clinic
20,000+ consultations a year
A single-centre, real-world site.
Studies
Three clinical studies
PRIMARY-India, TRANSFORM-INDIA and OSCAR.
Publications
15+ journal papers
Indian diabetes and internal medicine journals.
Advisory
25+ boards and panels
Advisory boards, expert panels and consensus meetings.

Research activities

Site Principal Investigator

PRIMARY-India

Sponsor: Sanofi · Protocol OBS16627

An observational study in primary care settings in India to assess clinical outcomes, initiation patterns and treatment satisfaction in people with type 2 diabetes starting insulin glargine. Prospective, India-only, about 447 patients. Hyderabad site; clinical study report finalised in 2025.

Investigator

TRANSFORM-INDIA

Sponsor: Emcure Pharmaceuticals, with QREC Clinical Research

Multicentre real-world obesity study. 2026 to present.

Investigator

OSCAR

Sponsor: Novo Nordisk

2025, including cardiovascular risk assessment work.

Selected publications

2026

Positioning of Semaglutide among Evolving Guidelines in the Management of Obesity and Related Comorbidities

International Journal of Diabetes and Technology · co-author

DOI 10.4103/ijdt.ijdt_20_26

2026

Rational Use of Dapagliflozin 5 mg: Real-World Prescribing Trends and a Practical ABCDEF Framework for Therapy Personalization

Journal of Diabetology · co-author, with Sanjay Kalra, A. G. Unnikrishnan, Rajeev Chawla and others

DOI 10.4103/jod.jod_124_25

2026

The Mechanism of Action of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction

Journal of the Association of Physicians of India · co-author

DOI 10.59556/japi.74.1294

2026

Understanding Hypertension in Indian Physicians: A Cross-Sectional Study of Blood Pressure

World Journal of Advanced Research and Reviews, 29(2) · co-author

DOI 10.30574/wjarr.2026.29.2.0291

2025

Optimizing Proton-Pump Inhibitor Therapy in Patients with Comorbidities Receiving Polypharmacy Treatment: Insights from Clinical Practice in India

Journal of the Association of Physicians of India (Scopus-indexed) · co-author

DOI 10.59556/japi.73.1185

2025

Understanding Diabetes Subtypes Through Patient Stories

Indian Diabetes Educator Journal (IDEJ), a USV-RSSDI initiative, Issue 128, pp. 4 to 9 · sole author

Co-author on ten published papers between 2019 and 2021, including The Mitochondrial Sugar Disease and Molecular Mechanism (IERJ, 2020), Portrayal of Biomarkers in Clinical Diagnosis of Diseases (IJPPR, 2020) and The Values and Visions of AI (IJCAR, 2020).

Active pipeline, 2026

Three manuscripts in preparation or under review: case reports on insulin-pump-managed type 2 diabetes with residual cardiovascular risk and on thyroid-metabolic care, and a narrative review of dietary fructose co-authored with a clinical pharmacology specialist.
A ten-survey national physician research programme on diabetes and obesity practice patterns, covering GLP-1 prescribing, treatment inertia, insulin initiation and diabetes technology. Fieldwork underway.
Patient-reported barriers to diabetes self-management: a single-centre survey of 138 respondents, under analysis for publication.

For CROs and medical affairs teams. He takes site-investigator roles in diabetes, obesity and cardiometabolic studies, and sits on advisory boards, expert panels and consensus meetings. Caspian Healthcare handles more than 20,000 consultations a year, which makes it viable as a single-centre real-world site.

Start a research conversation